Identity
What is GHRP-2?
A synthetic hexapeptide ghrelin-receptor agonist, also indexed as pralmorelin and KP-102.

Research reference · Hormones
GHRP-2 (pralmorelin) is a synthetic hexapeptide growth-hormone secretagogue. It has been used as a diagnostic test agent in Japan and studied in human endocrine research.
Published by Elevated Pharma ·
Identity
A synthetic hexapeptide ghrelin-receptor agonist, also indexed as pralmorelin and KP-102.
Research context
Human studies cover pharmacokinetics in children, GH release in critical illness and diagnostic testing of the pituitary.
Evidence boundary
Endocrine response data do not provide a general safety conclusion or establish an independently sourced material’s identity.
U.S. status · November 7, 2026
Not FDA-approved. GHRP-2 was not on FDA’s 2026 compounding advisory agendas.
Key studies
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
Search all 223 PubMed records for GHRP-2 · Counts and selections checked November 7, 2026.
Reference identifiers
Database identity describes the reference substance, not any specific material or lot.
Official & primary sources
Citation does not imply an Elevated Pharma partnership or endorsement.